Xvivo Perfusion AB (publ) (XVIPF)
OTCMKTS
· Delayed Price · Currency is USD
32.90
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of $1.05 billion as of June 6, 2025. Its market cap has decreased by -11.52% in one year.
Market Cap
1.05B
Enterprise Value
1.02B
Revenue
85.18M
Ranking
n/a
PE Ratio
76.76
Stock Price
$32.90
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 56.07M to 1.05B, an increase of 1,768.51%. That is a compound annual growth rate of 26.01%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.66B |
| Veradigm | 747.25M |
| Nika Pharmaceuticals | 666.65M |
| Tian'an Technology Group | 637.25M |
| Elite Pharmaceuticals | 619.60M |
| Glass House Brands | 443.99M |
| CytoDyn | 437.04M |
| Northwest Biotherapeutics | 364.12M |